Clinical Trial Update: A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating Sativex for central neuropathic pain in multiple sclerosis has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Neuropathic Pain

Drugs mentioned

• Sativex (nabiximol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Multiple Sclerosis, Neuropathic Pain | Phase 3 | Status: COMPLETED | Results posted: 2012-09-19